儿童异基因造血干细胞移植后罕见并发症及处理
Management of Rare Complications after Allogeneic Hematopoietic Stem Cell Transplantation in Children
摘要: 目的:探讨异基因造血干细胞移植(allo-genetic hematopoietic stem-cell transplantation, allo-HSCT)后植入功能不良(poor graft function, PGF)和抗利尿激素分泌不当综合征(syndrome of inappropriate antidiuretic hormone secretion, SIADH)的发病机制及治疗措施。分析本例患儿发病的可能原因。方法:报告1例重型再生障碍性贫血(aplastic anemia, AA)患儿allo-HSCT后临床特点及诊治经过。结果:患儿在allo-HSCT回输干细胞后出现II级超急性移植物抗宿主病(graft versus host disease, GVHD)。+17天突发昏迷、惊厥,完善检查示严重低钠血症,尿钠增多,血浆渗透压下降和尿渗透压升高,诊断为SIADH,经限液、补钠等支持治疗后好转。+15天血象未见明显回升,升白、升血小板治疗效果不佳,考虑原发性PGF。随访至移植后3月余仍需成分输血支持,后每月输注间充质干细胞1次(1 × 106/kg∙次,共3次)及血浆置换2次,达AA基本治愈的标准。结论:Allo-HSCT后PGF和SIADH均为严重的、可能导致不良预后的、威胁生命的并发症,其发病机制仍不明确,已知与和移植相关的多种因素相关。为此分析此病例探讨其机制及治疗措施,以改善患者的预后。
Abstract: Objective: To investigate the pathogenesis and treatment of poor graft function and syndrome of inappropriate antidiuretic hormone secretion after allogeneic hematopoietic stem cell transplantation, and analyze the possible causes of this case. Methods: The clinical characteristics, diagnosis and treatment of a case of severe aplastic anemia after allo-HSCT are reported. Results: Grade II hyperacute graft versus host disease occurred after allo-HSCT retransfusion of stem cells. 17 days after allo-HSCT after the onset of coma and convulsion, the improved examination showed severe hyponatremia, increased urinary sodium, decreased plasma osmotic pressure and increased urine osmotic pressure. The diagnosis was SIADH, which was improved after supported treatment such as fluid restriction and sodium supplementation. No significant recovery was observed in the blood images for 15 days after allo-HSCT, and the therapeutic effect of white and platelet rising was poor. Primary PGF was considered. The patients were followed up for more than 3 months after transplantation with the support of component blood transfusion. After that, the patients were injected with mesenchymal stem cells once a month (1 × 106/kg∙time, a total of 3 times) and plasmapheresis two times, reaching the standard of AA basic cure. Conclusions: Both PGF and SIADH after allo-HSCT are severe, potentially life-threatening complications with poor prognosis. Their pathogenesis is still unclear and is known to be associated with multiple factors associated with transplantation. Therefore, this case was analyzed to explore its mechanism and treatment measures to improve the prognosis of the patient.
文章引用:王丹旗, 姜健, 杨静, 孙立荣, 卢愿. 儿童异基因造血干细胞移植后罕见并发症及处理[J]. 临床医学进展, 2021, 11(1): 327-335. https://doi.org/10.12677/ACM.2021.111047

参考文献

[1] 师辰燕, Mamal, A., 刘增慧, 吴晓雄, 夏凌辉, 聂大年, 赖永榕, 等. 重型再生障碍性贫血行异基因造血干细胞移植后植入功能不良的危险因素分析[J]. 中华血液学杂志, 38(9): 761-766.
[Google Scholar] [CrossRef] [PubMed]
[2] 林果为, 王吉耀, 葛均波. 实用内科学[M]. 第15版. 北京: 人民卫生出版社, 2017: 2.
[3] Yuan, K. (2019) Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation—An Old Complication with New Insights. Seminars in Hematology, 56, 215-220.
[Google Scholar] [CrossRef] [PubMed]
[4] Zhao, Y.M., Gao, F., Shi, J.M., Luo, Y., Tan, Y.M., Lai, X.Y., et al. (2019) Incidence, Risk Factors, and Outcomes of Primary Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation, 25, 1898-1907.
[Google Scholar] [CrossRef] [PubMed]
[5] 韩明哲. 异基因造血干细胞移植后植入功能不良研究进展[J]. 临床血液学杂志, 2019, 32(9): 660-664. http://dx.chinadoi.cn/10.13201/j.issn.1004-2806.2019.09.003
[6] Sun, Y.Q., He, G.L., Chang, Y.J., Xu, L.-P., Zhang, X.-H., Han, W., et al. (2015) The Incidence, Risk Factors, and Outcomes of Primary Poor Graft Function after Unmanipulated Haploidentical Stem Cell Transplantation. Annals of Hematology, 94, 1699-705.
[Google Scholar] [CrossRef] [PubMed]
[7] Mainardi, C., Ebinger, M., Enkel, S., Feuchtinger, T., Teltschik, H.-M., Eyrich, M., et al. (2018) CD34+ Selected Stem Cell Boosts Can Improve Poor Graft Function after Paediatric Allogeneic Stem Cell Transplantation. British Journal of Haematology, 180, 90-99.
[Google Scholar] [CrossRef] [PubMed]
[8] Xiao, Y., Song, J.Y., Jiang, Z.J., Li, Y.H., Gao, Y., Xu, W.N., et al. (2014) Risk-Factor Analysis of Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation. International Journal of Medical Sciences, 11, 652-657.
[Google Scholar] [CrossRef] [PubMed]
[9] Rowley, S.D., Liang, P.S. and Ulz, L. (2000) Transplantation of ABO-Incompatible Bone Marrow and Peripheral Blood Stem Cell Components. Bone Marrow Transplant, 26, 749-757.
[Google Scholar] [CrossRef] [PubMed]
[10] Benjamin, R.J., Connors, J.M., McGurk, S., Hallowell Churchill, W. and Antin, J.H (1998) Prolonged Erythroid Aplasia after Major ABO-Mismatched Transplantation for Chronic Myelogenous Leukemia. Biol Blood Marrow Transplant, 4, 151-156.
[Google Scholar] [CrossRef] [PubMed]
[11] Torok-Storb, B., Boeckh, M., Hoy, C., Leisenring, W., Myerson, D. and Gooley, T. (1997) Association of Specific Cytomegalovirus Genotypes with Death from Myelosuppression after Marrow Transplantation. Blood, 90, 2097-102.
[12] Song, Y., Zhao, H.Y., Lyu, Z.S., Cao, X.-N., Shi, M.-M., Wen, Q., et al. (2018) Dysfunctional Bone Marrow Mesenchymal Stem Cells in Patients with Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation, 24, 1981-1989.
[Google Scholar] [CrossRef] [PubMed]
[13] Mohty, R., Brissot, E., Battipaglia, G., Ruggeri, A., Sestili, S., Mediavilla, C., et al. (2019) CD34+-Selected Stem Cell “Boost” for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation. Current Research in Translational Medicine, 67, 112-114.
[Google Scholar] [CrossRef] [PubMed]
[14] 刘晓丹, 范志平, 彭延文, 黄芬, 江千里, 张贤, 等. 第三方骨髓间充质干细胞治疗异基因造血干细胞移植后植入功能不良[J]. 中华血液学杂志, 2011, 33(2): 98-102. http://dx.chinadoi.cn/10.3760/cma.j.issn.0253-2727.2012.02.007
[15] Olivieri, J., Mancini, G., Goteri, G., Scortechini, I., Giantomassi, F., Chiarucci, M. (2016) Reversal of Poor Graft Function with Iron-Chelating Therapy after Allogeneic Transplantation for Severe Aplastic Anemia. Leukemia & Lymphoma, 57, 965-968.
[Google Scholar] [CrossRef] [PubMed]
[16] Wei, J., Xiao, Y., Yu, X., Zhou, J. and Zhang, Y. (2010) Early Onset of Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) after Allogeneic Haematopoietic Stem Cell Transplantation: Case Report and Review of the Literature. Journal of International Medical Research, 38, 705-710.
[Google Scholar] [CrossRef] [PubMed]
[17] Paul, G., John, A., Pierre-Marc, B., Cohen, M., Cranston, I., Murray, R.D., et al. (2015) The Diagnosis and Management of Inpatient Hyponatraemia and SIADH. European Journal of Clinical Investigation, 45, 888-894.
[Google Scholar] [CrossRef] [PubMed]
[18] 江倩, 刘开彦, 黄晓军, 卢纹凯. 异基因造血干细胞移植后的抗利尿激素分泌失调综合征一例报告——附文献复习[J]. 中华血液学杂志, 2006(2): 78-81.
[19] 邹德慧, 王东浩, 王迎, 赵耀中, 薛华, 李妍, 等. 非亲缘异基因造血干细胞移植后的血管升压素分泌失调综合征[J]. 中华内科杂志, 2006, 45(10): 853-854. http://dx.chinadoi.cn/10.3760/j.issn:0578-1426.2006.10.023
[20] 张翔, 肖毅, 张义成, 耿哲, 周剑峰, 余学锋, 等. 异基因造血干细胞移植后抗利尿激素分泌失调综合征诊治体会[J]. 内科急危重症杂志, 2009, 15(3): 161-163. http://dx.chinadoi.cn/10.3969/j.issn.1007-1024.2009.03.018
[21] 肖毅, 张义成, 隗佳, 孙汉英, 刘文励, 周剑峰. 异基因造血干细胞移植后的抗利尿激素分泌失调综合征[C]//中国病理生理学会实验血液学专业委员会. 第12届全国实验血液学会议论文摘要. 中国病理生理学会实验血液学专业委员会: 中国病理生理学会, 2009: 1.
[22] Rau, R., Fitzhugh, C.D., Baird, K., Cortez, K.J., Li, L., Fischer, S.H., et al. (2008) Triad of Severe Abdominal Pain, Inappropriate Antidiuretic Hormone Secretion, and Disseminated Varicella-Zoster Virus Infection Preceding Cutaneous Manifestations After Hematopoietic Stem Cell Transplantation: Utility of PCR for Early Recognition and Therapy. The Pediatric Infectious Disease Journal, 27, 265-268.
[Google Scholar] [CrossRef
[23] Peri, A., Pirozzi, N., Parenti, G., Festuccia, F. and Menè, P. (2010) Hyponatremia and the Syndrome of Inappropriate Secretion of Antidiuretic Hormone (SIADH). Journal of Endocrinological Investigation, 33, 671-682.
[Google Scholar] [CrossRef
[24] 李银英, 邱磊, 王淑亮. 抗利尿激素分泌失调综合征临床研究现状[J]. 继续医学教育, 2017, 31(6): 74-76.
[25] 邵珠林, 徐向进. 结合指南看抗利尿激素分泌异常综合征的最新诊疗进展[J]. 内科急危重症杂志, 2016, 22(4): 247-249.